Venture capital firm 14Peaks Capital has successfully closed its first fund at $30 million in capital commitments from an impressive consortium of limited partners (LPs), consisting of influential High Net Worth Individuals (HNIWs) and family offices spanning Europe and the United States.
Lausanne, Switzerland-based Debiopharm Innovation Fund, the strategic investment arm of Swiss biopharmaceutical company Debiopharm, has announced the launch